Spring Bank Pharmaceuticals Nasdaq Listed Banner

News Releases

  • Webcast Image Webcast
    Spring Bank/F-Star Business Combination  (Replay)
    Thursday, July 30, 2020 7:30 am EDT
Toggle Summary Spring Bank Pharmaceuticals Presents Study Results for Novel Anti-Viral Pharmaceuticals from its Small Molecule Nucleic Acid Hybrid technology platform
Milford, MA – February 2010 – Spring Bank Pharmaceuticals, Inc., a  biopharmaceutical company capitalizing on its proprietary Small Molecule Nucleic Acid  Hybrid technology platform announced today that it will present four (4) posters on it  breakthrough products for the treatment